NKT and NKT-like Cells in Autoimmune Neuroinflammatory Diseases-Multiple Sclerosis, Myasthenia Gravis and Guillain-Barre Syndrome
- PMID: 34502425
- PMCID: PMC8431671
- DOI: 10.3390/ijms22179520
NKT and NKT-like Cells in Autoimmune Neuroinflammatory Diseases-Multiple Sclerosis, Myasthenia Gravis and Guillain-Barre Syndrome
Abstract
NKT cells comprise three subsets-type I (invariant, iNKT), type II, and NKT-like cells, of which iNKT cells are the most studied subset. They are capable of rapid cytokine production after the initial stimulus, thus they may be important for polarisation of Th cells. Due to this, they may be an important cell subset in autoimmune diseases. In the current review, we are summarising results of NKT-oriented studies in major neurological autoimmune diseases-multiple sclerosis, myasthenia gravis, and Guillain-Barre syndrome and their corresponding animal models.
Keywords: EAE; MS; NKT; iNKT; multiple sclerosis; myasthenia gravis.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
[Experience of treating facial neuritis, unexplained limb weakness, cervical spondylosis, acute myelitis, acute radiculitis, Guillain Barre syndrome, multiple sclerosis, myasthenia gravis, motor neuron disease, dermatomyositis with Xiaoxuming Decoction].Zhongguo Zhong Yao Za Zhi. 2020 Jun;45(12):2735-2751. doi: 10.19540/j.cnki.cjcmm.20200328.501. Zhongguo Zhong Yao Za Zhi. 2020. PMID: 32627446 Chinese.
-
Mannose-binding Lectin Mediated Complement Pathway in Autoimmune Neurological Disorders.Iran J Allergy Asthma Immunol. 2016 Jun;15(3):251-6. Iran J Allergy Asthma Immunol. 2016. PMID: 27424141 Clinical Trial.
-
[Neuroimmunological diseases: update].Nihon Rinsho. 2013 May;71(5):771-7. Nihon Rinsho. 2013. PMID: 23777080 Review. Japanese.
-
Combined Guillain-Barré syndrome and myasthenia gravis.Brain Dev. 2013 Oct;35(9):865-9. doi: 10.1016/j.braindev.2012.10.016. Epub 2012 Nov 22. Brain Dev. 2013. PMID: 23177060
-
Role of NK cells and invariant NKT cells in multiple sclerosis.Results Probl Cell Differ. 2010;51:127-47. doi: 10.1007/400_2009_11. Results Probl Cell Differ. 2010. PMID: 19582416 Review.
Cited by
-
Harnessing Chimeric Antigen Receptor-engineered Invariant Natural Killer T Cells: Therapeutic Strategies for Cancer and the Tumor Microenvironment.Curr Pharm Biotechnol. 2024;25(15):2001-2011. doi: 10.2174/0113892010265228231116073012. Curr Pharm Biotechnol. 2024. PMID: 38310449 Review.
-
Identification of immune subsets with distinct lectin binding signatures using multi-parameter flow cytometry: correlations with disease activity in systemic lupus erythematosus.Front Immunol. 2024 May 7;15:1380481. doi: 10.3389/fimmu.2024.1380481. eCollection 2024. Front Immunol. 2024. PMID: 38774868 Free PMC article.
-
The Plasticity of Immune Cell Response Complicates Dissecting the Underlying Pathology of Multiple Sclerosis.J Immunol Res. 2024 Jan 4;2024:5383099. doi: 10.1155/2024/5383099. eCollection 2024. J Immunol Res. 2024. PMID: 38213874 Free PMC article. Review.
-
Editorial: Neuroinflammatory aspects in neurological disorders.Front Mol Med. 2025 Feb 11;5:1557546. doi: 10.3389/fmmed.2025.1557546. eCollection 2025. Front Mol Med. 2025. PMID: 40012853 Free PMC article. No abstract available.
-
The Effect of Peripheral Immune Cell Counts on the Risk of Multiple Sclerosis: A Mendelian Randomization Study.Front Immunol. 2022 May 10;13:867693. doi: 10.3389/fimmu.2022.867693. eCollection 2022. Front Immunol. 2022. PMID: 35619713 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical